Latest stories on MIRM
Stifel reiterates Mirum Pharmaceuticals stock rating after rival trial fails
Investing.com Analyst Ratings63 · neutralanalyst
Mirum Advances New Drug Candidate With Fresh Phase 1 Study Update
TipRanks63 · neutralproduct/pr
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MIRM Stock News
StockTitan50 · neutralgeneral
Mirum Pharmaceuticals: This Liver Disease Juggernaut Just Broadened Its Portfolio
Seeking Alpha67 · bullishproduct/pr
Is Mirum Pharmaceuticals, Inc. (MIRM) Emerging as a Rare Disease Growth Story After New FOP Data?
Yahoo Top63 · neutralanalyst
Mirum Pharmaceuticals, Inc. (MIRM) files 8-K
SEC 8-K50 · neutralgeneral
Mirum and Incyte's zilurgisertib shows positive Phase 2 data in FOP
Seeking Alpha73 · bullishproduct/pr
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | MIRM Stock News
StockTitan50 · neutralgeneral
Mirum Pharmaceuticals (MIRM) Reports Positive Phase 2b Data for Volixibat in PSC at EASL Congress
Yahoo Top73 · bullishproduct/pr
Mirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline Advance
Yahoo Finance73 · bullishproduct/pr
Mirum Pharma: A Rare Disease Growth Story to Watch
MarketBeat58 · neutralproduct/pr
Mirum Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings